Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. Experience: Use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities

Canadian Association of Radiologists Journal

Volumn 56, Issue 2, 2005, Pages 82-93

  Caines, Judy S ^a,b   Schaller, Gerald H ^a   Iles, Siân E ^a   Woods, Eric R ^a   Barnes, Penny J ^a   Johnson, Alphonse J ^a   Jones, Gordon R M ^a   Borgaonkar, Joy N ^a   Rowe, Judy A ^a   Topp, Trevor J ^a   Porter, Geoffrey A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST SURGERY; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NOVA SCOTIA; PROGRAM EVALUATION; TIME FACTORS;

EID: 20444497720     PISSN: 08465371     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644-56.
2. Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:937-78.
3. Tabar L, Fagerberg G, Duffy SW. Update of the Swedish two-country program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
4. Roberts MM, Alexander F, Anderson TJ. Edinburgh trail of screening for breast cancer: mortality at seven years. Lancet 1990;335:241-6.
5. Frisell J, Klund G, Hellstrom L. Randomized study of mammographic screening: preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18:49-56.
6. Shapiro S, Venet W, Strax P, editors. Periodic screening for breast cancer. Baltimore (MD): John Hopkins University Press; 1988.
7. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;297:943-8.
8. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials February 25, 1993;doc 32
9. Kerlikowske K, Grady D, Rubin SM. Efficacy of screening mammography: a meta-analysis. JAMA 1995;274:149-54.
10. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 and 50 to 69 years: comparison of relative and absolute benefit. Natl Cancer Inst Monogr 1997;22:79-86.
11. Hendrick RE, Smith RA, Rutledge JH III, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. Natl Cancer Inst Monogr 1997;22:87-92.
12. Larsson L-G, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, et al. Updated overview of the Swedish randomized trials on breast cancer screening with mammography: age group 40-49 at randomization. Natl Cancer Inst Monogr 1997;22:57-61.
13. Sickles EA, Ominsky SH, Sollitto RA, Calvin HB, Monticciolo DL. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology 1990;175:323-7.
14. Bird RE. Low-cost screening mammography: report on finances and review of 21,716 consecutive cases. Radiology 1989;171:87-90.
15. Spring DB, Kimbrell-Wilmot K. Evaluating the success of mammography at the local level: how to conduct an audit of your practice. Radiol Clin North Am 1987;25:983-92.
16. Margolin FR, Lagios MD. Development of mammography and breast services in a community hospital. Radiol Clin North Am 1987;25:973-82.
17. Health Canada. Report from the Evaluation Indicators Working Group. Guidelines for monitoring breast screening program performance. Ottawa (ON): Minister of Public Works and Government Services Canada; 2002. Cat. No.: H39-617/2002.
18. Health Canada. Organized breast cancer screening programs in Canada: 1996 report. Ottawa (ON): Minister of Public Works and Government Services Canada; 1999. Cat. No.: H1-9/13-1999.
19. Health Canada. Organized breast cancer screening programs in Canada: 1997 and 1998 report. Ottawa (ON): Minister of Public Works and Government Services Canada; 2001. Cat. No.: H1-9/13-1998.
20. Health Canada. Organized breast cancer screening programs in Canada: 1999 and 2000 report. Ottawa (ON): Minister of Public Works and Government Services Canada; 2003. Cat. No.: H1-9/13-2000.
21. Health Canada. Quality determinants of organized breast cancer screening programs. Ottawa (ON): Minister of Public Works and Government Services Canada; 1997. Cat. No.: H39-407/1997E.
22. Health Canada. Quality determinants of organized breast cancer screening programs. Ottawa (ON): Minister of Public Works and Government Services Canada; 1997. Cat. No.: H39-407/2003E.
23. Health Canada. Canadian Breast Cancer Initiative. Questions and answers on breast cancer. A guide for women and their physicians. Based on "The Canadian Clinical Practice Guidelines for the Care and Treatment of Breast Cancer." CMAJ 1998; 158(Suppl 3).
24. Health Canada. Report of the working group on the integration of screening and diagnosis for the Canadian Breast Cancer Screening Initiative. Ottawa (ON): Minister of Public Works and Government Services Canada; 2000. Cat. No.: H39-526/2000E.
25. Health Canada. Waiting for a diagnosis after an abnormal breast screen in Canada. Ottawa (ON): Minister of Public Works and Government Services Canada; 2000. Cat. No.: H39-526/2000E.
26. Olivotto IA, Gomi A, Bancej C, Brisson J, Tonita J, Kan L, et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 2002;94:2143-50.
27. Government of Nova Scotia. Performance measurement and health informatics (PMHI). 1996 census report. Halifax (NS); Government of Nova Scotia; 1996.
28. Caines JS, McPhee MD, Konok GP, Wright BA. Stereotaxic needle core biopsy of breast lesions using a regular mammogrpahic table with an adaptable stereotaxic device. AJR Am J Roentgenol 1994;163:317-321.
29. Caines JS, Chantziantoniou K, Wright BA, Konok GP, Iles SE, Bodurtha A, et al. Nova Scotia Breast Screening Program Experience: use of needle core biopsy in the diagnosis of screening-detected abnormalities. Radiology 1996;198:125-30.
30. Olivotto IA, Kan L, d'Yachkova Y, Burhenne LJ, Hayes M, Hislop TG, et al. Ten years of breast screening in the screening mammography program of British Columbia, 1988-97. J Med Screen 2000;7:152-9.
31. Libstug AR, Moravan V, Aitken SE. Results from the Ontario breast screening program, 1990-1995. J Med Screen 1998;5:73-80.
32. Paquette D, Snider J, Bouchard F, Olivotto, Bryant H, Decker K, et al. Performance of screening mammography in organized programs in Canada in 1996. Database Management Subcommittee to the Canadian Breast Cancer Screening Initiative. CMAJ 2000;163:1133-8.